Document is current
Any future updates will be listed below
-
Authors
,
Mellado-Artigas, Ricard http://orcid.org/0000-0003-2815-6819
Ferreyro, Bruno L.
Angriman, Federico
Hernández-Sanz, María
Arruti, Egoitz
Torres, Antoni
Villar, Jesús
Brochard, Laurent
Ferrando, Carlos
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (#CB06/06/1088; #PI16/00049; #PI18/01611; #PI19/00141, (#CB06/06/1088; #PI16/00049; #PI18/01611; #PI19/00141)
Canadian Institute of Health Research
- License Information
-
More Information
Article History
Received: 7 December 2020
Accepted: 13 January 2021
First Online: 11 February 2021
Ethics approval and consent to participate
: The study was approved by the referral Ethics Committee of Hospital Clínic, Barcelona, Spain (#HCB/2020/0399).
: Not applicable.
: A. Torres reports lecturing or consultancy fees from Pfizer, MSD, Basilea, Biomerieux. Jansen. L. Brochard's laboratory reports grants from Medtronic Covidien, grants and non-financial support from Fisher Paykel, non-financial support from Air Liquide, Sentec, Philips, and a patent with General Electric, outside the submitted work. The remaining authors declare no conflicts of interest in relation to this manuscript.
